These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

584 related items for PubMed ID: 20013565

  • 1. Experience with mycophenolate mofetil as maintenance therapy in five pediatric patients with severe systemic lupus erythematosus.
    Dittrich K, Ross S, Benz K, Amann K, Dötsch J.
    Klin Padiatr; 2009 Dec; 221(7):425-9. PubMed ID: 20013565
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus.
    Buratti S, Szer IS, Spencer CH, Bartosh S, Reiff A.
    J Rheumatol; 2001 Sep; 28(9):2103-8. PubMed ID: 11550982
    [Abstract] [Full Text] [Related]

  • 3. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N, Ingsathit A, Rattanasiri S, Ngamjanyaporn P, Kasitanont N, Chawanasuntorapoj R, Pichaiwong W, Anutrakulchai S, Sangthawan P, Ophascharoensuk V, Avihingsanon Y, Sumethkul V.
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [Abstract] [Full Text] [Related]

  • 4. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC, Ying KY, Yim CW, Siu YP, Tong KH, To CH, Ng WL.
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [Abstract] [Full Text] [Related]

  • 5. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U, Bauer H, Märker-Hermann E.
    Dtsch Med Wochenschr; 2006 Oct 13; 131(41):2266-9. PubMed ID: 17036267
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil as maintenance therapy for childhood-onset systemic lupus erythematosus patients with severe lupus nephritis.
    Kizawa T, Nozawa T, Kikuchi M, Nagahama K, Okudela K, Miyamae T, Imagawa T, Nakamura T, Mori M, Yokota S, Tsutsumi H.
    Mod Rheumatol; 2015 Mar 13; 25(2):210-4. PubMed ID: 25159157
    [Abstract] [Full Text] [Related]

  • 7. Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen.
    Fujinaga S, Ohtomo Y, Hara S, Umino D, Someya T, Shimizu T, Kaneko K.
    Pediatr Nephrol; 2008 Oct 13; 23(10):1877-82. PubMed ID: 18414900
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C, Crowson CS, Matteson EL, Moder KG.
    Lupus; 2009 Apr 13; 18(5):394-9. PubMed ID: 19318390
    [Abstract] [Full Text] [Related]

  • 9. Maintenance therapies for proliferative lupus nephritis: mycophenolate mofetil, azathioprine and intravenous cyclophosphamide.
    Contreras G, Tozman E, Nahar N, Metz D.
    Lupus; 2005 Apr 13; 14 Suppl 1():s33-8. PubMed ID: 15803929
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil in the treatment of systemic lupus erythematosus.
    Dall'Era M.
    Curr Opin Rheumatol; 2011 Sep 13; 23(5):454-8. PubMed ID: 21720247
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
    Lourdudoss C, Vollenhoven Rv.
    Lupus; 2014 Mar 13; 23(3):299-304. PubMed ID: 24399811
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM, Sahin S, Kiziltas S, Masatlioglu S, Oguz F, Ergin H.
    Ren Fail; 2008 Mar 13; 30(9):865-9. PubMed ID: 18925525
    [Abstract] [Full Text] [Related]

  • 13. Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine.
    Fischer-Betz R, Specker C, Brinks R, Aringer M, Schneider M.
    Rheumatology (Oxford); 2013 Jun 13; 52(6):1070-6. PubMed ID: 23382355
    [Abstract] [Full Text] [Related]

  • 14. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S, Berden JH, Grootscholten C, Derksen RH, Berger SP, de Sévaux RG, Voskuyl AE, Bijl M, Dutch Working Party on SLE.
    Neth J Med; 2014 Nov 13; 72(9):481-90. PubMed ID: 25431394
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate Mofetil and New-Onset Systemic Lupus Erythematosus: A Randomized Clinical Trial.
    You Y, Zhou Z, Wang F, Li J, Liu H, Cheng X, Su Y, Chen X, Zheng H, Sun Y, Shi H, Hu Q, Xu J, Teng J, Yang C, Ye J.
    JAMA Netw Open; 2024 Sep 03; 7(9):e2432131. PubMed ID: 39283640
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N, Kurian J, Agarwal V, Bhadauria D, Behera M, Yacha M, Kushwaha R, Agrawal V, Jain M, Gupta A.
    Lupus; 2020 Jul 03; 29(8):845-853. PubMed ID: 32437258
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in systemic lupus erythematosus: results from a retrospective study in a large monocentric cohort and review of the literature.
    Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
    Immunol Res; 2014 Dec 03; 60(2-3):270-6. PubMed ID: 25468307
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB, Won S, Bae SC.
    Lupus; 2018 May 03; 27(6):1007-1011. PubMed ID: 29448881
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis.
    Feng L, Deng J, Huo DM, Wu QY, Liao YH.
    Nephrology (Carlton); 2013 Feb 03; 18(2):104-10. PubMed ID: 23113811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.